Neurofibromatosis Type 1 (von Recklinghausen's disease) in Pregnancy: cesarean delivery outcomes – case report
##plugins.themes.bootstrap3.article.main##
##plugins.themes.bootstrap3.article.sidebar##
Abstract
##plugins.themes.bootstrap3.article.details##
Neurofibromatosis type 1, von Recklinghausen, pregnancy, cesarean delivery
2. Pilmore H, Na Nagara M, Walker R. Neurofibromatosis and renovascular hypertension presenting in early pregnancy. Nephrol Dial Transplant 1997; 12:187–189
3. Stefanidis K, Solomou E, Lagona E, et al. MRI investigation for neurofibromatosis type 1 lesions during pregnancy-a case report. Clin Exp Obstet Gynecol 2006; 33(4):246-8.
4. Terzi YK, Oguzkan-Balci S, Anlar B, et al. Reproductive decisions after prenatal diagnosis in neurofibromatosis type 1: importance of genetic counseling. Genet Couns 2009; 20(2):195-202.
5. Weissman A, Jakobi P, Zaidise I, Drugan A. Neurofibromatosis and pregnancy. An update. J Reprod Med 1993; 38(11):890-96.
6. Sangwan N, Duhan N. Normal Obstetric Outcome in Neurofibromatosis-1 Complicating Pregnancy. JK Science 2008; 10(4):197-198.
7. Bongiorno MR, Doukaki S, Aricò M. Neurofibromatosis of the nipple-areolar area: a case series. J Med Case Rep 2010; 4:22.
8. Zanca A, Zanca A. Antique illustrations of neurofibromatosis. Int J Dermato 1980; 19(1):55-8.
9. Crump T. Translation of case reports in Ueber die multiplen Fibrome der Haut und ihre Beziehung zu den multiplen Neuromen by F. v. Recklinghausen. Adv Neurol 1981; 29:259-75.
10. Ferner R, Huson S, Thomas N, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 2007; 44(2):81–88.
11. Ruggierei M, Huson SM. The clinical and diagnostic implications of mosaicism in the neurofibromatoses. Neurology 2001; 56(11):1433–43.
12. Korf BR, Huson SM. The Phakamatoses. In: Rimoin D, Connor JM, Pyeritz RE, Korf BR, eds. Principles and practice of medical genetics, 5th edn. Edinburgh: Churchill Livingstone 2006; 90(6):924-7.
13. Bandipalliam P. Syndrome of early onset colon cancer, haematological malignancy and features of neurofibromatosis in HNPCC families with homozygous mismatch repair gene mutations. Fam Cancer 2005; 4(4):323-33.
14. De Luca A, Bottiloo I, Sarkozy A, et al. NF1 gene mutations represent the major molecular event underlying neurofibromatosis–Noonan syndrome. Am J Med Genet 2005; 77(6):1092-101.
15. Evans DGR, Moran A, King A, et al. Incidence of vestibular schwannoma and neurofibromatosis 2 in the north west of England over a 10‐year period: higher incidence than previously thought. Otol Neurotol 2005; 26(1):93-7.
16. Trofatter J, MacCollin M, Rutter JL, et al. A novel moesin–esrin–radixin‐like gene is a candidate for the neurofibromatosis 2 tumours suppressor. Cell 1993; 72(5):791-800.
17. Evans DGR, Huson SM, Donnai D, et al. A clinical study of type 2 neurofibromatosis. Q J Med 1992; 84(304):603-18.
18. MacCollin M, Chiocca EA, Evans DG, et al. Diagnostic criteria for schwannomatosis. Neurology 2005; 64(11):1838-45.
19. *** Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 1988; 45(5):575-8.
20. Viskochil D, Buchberg AN, Xu G, et al. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 1990; 62(1):187-92.
21. Wallace MR, Marchuk DA, Anderson LB, et al. Type 1 neurofibromatosis gene; identification of a larger transcript disrupted in three NF1 patients. Science 1990; 249(4965):181-6.
22. Xu GF, O'Connell P, Viskochil D, et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 1990; 62(3):599-608.
23. Gutmann DH, Wood DL, Collins FS. Identification of the neurofibromatosis 1 gene product. Proc Natl Acad Sci USA 1991; 88(21):9658-62.
24. Daston MM, Scrable H, Nordlund M, et al. The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells and oligodendrocytes. Neuron 1992; 8(3):415-28.
25. Lammert M, Mautner V, Kluwe L. Do hormonal contraceptives stimulate growth of neurofibromas? A survey on 59 NF1 patients. BMC Cancer 2005; 5:16.
26. Dugoff L, Sujansky E. Neurofibromatosis type 1 and pregnancy. Am J Med Genet 1996; 66(1):7-10.
27. National Institute of Neurological Disorders and Stroke-NINDS Neurofibromatosis Information Page [http://www.ninds.nih.gov/disorders/neurofibromatosis/neurofibromatosis.htm available at 9.09.2014]
28. Hsieh DT. Neurofibromatosis Type 1. Medscape [http://emedicine.medscape.com/article/1177266-overview available at 9.09.2014]
29. Pastore JO, Yurchak PM, Janis KM, Murphy JD, Zir LM. The risk of advanced heart block in surgical patients with right bundle branch block and left axis deviation. Circulation 1978; 57:677-680.
30. Salgaonkar S, Chaudhari L. Anaesthetic management of emergency cesarean section in a case of myocardial infarction with left ventricular dysfunction. Indian J Anaesth 2003; 47(4):293-295.
31. Dorman T, Breslow MJ, Pronovost PJ, Rock P, Rosenfeld BA. Bundle-branch block as a risk factor in noncardiac surgery. Arch Intern Med 2000; 160(8):1149-52.
Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at www.clinicalcases.eu and our digital applications is intended for personal noncommercial use.
Authors who submit a manuscript for publication in Archive of Clinical Cases agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.
Guidelines for linking to www.clinicalcases.eu a. The main purpose of the site linking to the Archive of Clinical Casess site should be educational. b. Links should be made to the Archive of Clinical Casess home page (www.clinicalcases.eu) or to the articles abstract. c. It is forbidden to use the Archive of Clinical Casess cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.